Chest Medicine (all articles)
Choosing Wisely in the COVID-19 Era: Preventing Harm to Healthcare Workers
22 May, 2020 | 04:58h | UTC
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
22 May, 2020 | 04:59h | UTCCommentary: Lungs of deceased COVID-19 patients show distinctive features – Brigham and Women’s Hospital
Related: Postmortem Examination of Patients With COVID-19 – JAMA AND Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine AND Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
How Coronavirus Lockdowns Stopped Flu in its Tracks
22 May, 2020 | 04:53h | UTCHow coronavirus lockdowns stopped flu in its tracks – Nature
“Reported rates of influenza and other infections have fallen sharply, but some communicable diseases may see a rise.”
15 Drugs Being Tested to Treat COVID-19 and How They Would Work
22 May, 2020 | 04:52h | UTC15 drugs being tested to treat COVID-19 and how they would work – Nature
[Preprint] IL6 Inhibition in Critically Ill COVID-19 Patients is Associated with Increased Secondary Infections
22 May, 2020 | 04:44h | UTC
Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
21 May, 2020 | 09:23h | UTCRelated: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
Olfactory Dysfunction in COVID-19: Diagnosis and Management
21 May, 2020 | 09:24h | UTCOlfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA
Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford
Editorial: Unconventional Approaches to Mechanical Ventilation Through the COVID-19 Crisis
21 May, 2020 | 09:22h | UTC
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv
Video: Personal Protective Equipment and Covid-19
20 May, 2020 | 09:55h | UTCPersonal Protective Equipment and Covid-19 – New England Journal of Medicine
Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City
20 May, 2020 | 09:56h | UTCCommentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI
Meta-Analysis: Accuracy of Chest CT for detecting COVID-19
20 May, 2020 | 09:49h | UTC
Should Azithromycin be Used to Treat COVID-19?
20 May, 2020 | 09:47h | UTCShould azithromycin be used to treat COVID-19? A rapid review – BJGP Open
Cross-neutralization of SARS-CoV-2 by a Human Monoclonal SARS-CoV Antibody
19 May, 2020 | 04:35h | UTCCross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody – Nature
Commentary: Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody – News Medical
Early Data Show Moderna Covid-19 Vaccine Generates Immune Response
19 May, 2020 | 04:29h | UTCEarly data show Moderna Covid-19 vaccine generates immune response – STAT
See also: Moderna Coronavirus Vaccine Trial Shows Promising Early Results – The New York Times AND Expert reaction to Moderna announcement about their phase 1 trial data on their mRNA vaccine (mRNA-1273) candidate against COVID-19 – Science Media Centre
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology
19 May, 2020 | 04:20h | UTC
New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease
18 May, 2020 | 02:15h | UTCCOVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence
See also: Complete Collection of Covid-19 Rapid Guidelines
Randomized Trial: No Benefit from Hydroxychloroquine in Patients with Mild to Moderate Covid-19
18 May, 2020 | 02:11h | UTCCommentary: Further evidence does not support hydroxychloroquine for patients with COVID-19 – BMJ
Clinical Practice: Severe Covid-19
18 May, 2020 | 02:09h | UTCSevere Covid-19 – New England Journal of Medicine
Hemostasis Disorders in Critically Ill Patients with COVID-19
18 May, 2020 | 02:08h | UTC
Related Commentary on Twitter
Understanding pathophysiology of hemostasis
What is the link between SARS-CoV-2-associated hypoxia, inflammatory response and both hypercoagulability and endotheliopathy observed in #COVID19 patients?! @yourICM https://t.co/xu0M0FiYcr pic.twitter.com/nm2JB9OKTH— Antibiotic Steward? Bassam Ghanem (@ABsteward) May 16, 2020
LDH, Lymphocyte Count, and C-reactive protein can Predict Mortality in Covid-19
18 May, 2020 | 01:58h | UTCAn interpretable mortality prediction model for COVID-19 patients – Nature Machine Learning
Related Commentary on Twitter
The importance of 3 blood test results for predicting mortality from #COVID19: LDH, lymphocyte count, and C-reactive protein https://t.co/BpbgLkm6Hs just published @NatMachIntell, a nice example of machine learning deconvoluting risk markers pic.twitter.com/JtBofSdwsM
— Eric Topol (@EricTopol) May 14, 2020
Guidance for Tracheostomy in the COVID-19 Era
18 May, 2020 | 02:05h | UTCCommentary: Walking the line between benefit and harm from tracheostomy in COVID-19 – The Lancet Respiratory Medicine
Clinical and Chest Radiography Features Determine Patient Outcomes In COVID-19
18 May, 2020 | 01:59h | UTC